ORIGINAL RESEARCH article
Front. Digit. Health
Sec. Health Technology Implementation
One view to rule them all? Artificial Intelligence Assessment of Valvular Disease and Ventricular Function by a Single Echocardiography View
Provisionally accepted- 1Sheba medical center Division of Cardiology, Ramat gan, Israel
- 2Tel Aviv University, Tel Aviv-Yafo, Israel
- 3Sheba Medical Center, Ramat Gan, Israel
- 4sheba medical center Department of Otolaryngology — Head and Neck Surgery, Ramat Gan, Israel
- 5Tel Aviv University Faculty of Medical and Health Sciences, Tel Aviv-Yafo, Israel
- 6Hebrew University of Jerusalem Faculty of Medicine,, Jerusalem, Israel
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
ABSTRACT Background : Valvular heart disease and heart failure are major global health burdens, yet access to comprehensive echocardiography is often limited, particularly in resource-constrained settings. Artificial intelligence (AI) may enable rapid, point-of-care cardiac assessment using simplified imaging protocols . Objectives : To evaluate whether a deep learning model can accurately detect significant valvular and ventricular dysfunction using only a single two-dimensional apical four-chamber echocardiographic view, including images acquired by non-cardiologists with handheld ultrasound devices . Methods: We retrospectively analyzed 120,127 echocardiographic studies from a tertiary medical center to train and validate a deep learning model for identifying moderate-or-greater mitral or tricuspid regurgitation, right ventricular dysfunction, and reduced left ventricular ejection fraction (≤40%). A prospective cohort of 209 patients underwent handheld point-of-care cardiac ultrasound performed by non-cardiologist physicians, with same-hospitalization comprehensive echocardiography as the reference standard . Results: In retrospective testing, model areas under the curve (AUCs) were 0.883 for mitral regurgitation, 0.913 for tricuspid regurgitation, 0.940 for right ventricular dysfunction, and 0.982 for reduced ejection fraction. In the prospective cohort, AUCs were 0.72, 0.87, 0.95, and 0.97 for the same respective targets . Conclusions: A single-view deep learning model demonstrated strong diagnostic accuracy for detecting significant valvular and ventricular dysfunction across both standard and handheld ultrasound acquisitions. This approach may facilitate rapid, scalable cardiac function screening by non-cardiologists in diverse clinical environments . (Clinical Trial Registration: NCT05455541).
Keywords: artificial intelligence, Heart Failure, Echocardiography, Point-of-care imaging, Valvular Heart Disease
Received: 13 Aug 2025; Accepted: 02 Dec 2025.
Copyright: © 2025 Fisher, Fiman, Segal, Lidar, Rubin, Am-Shalom, Cohen, Faierstein, Tsur, Schwammenthal, Klempfner, Zimlichman, Raanani and Maor. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Lior Fisher
Elad Maor
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
